Home › Mutual Funds › Nippon India Mutual Fund › Nippon India Pharma Fund Direct Plan Payout Inc Dist cum Cap Wdrl
Latest NAV & returns of NIPPON INDIA PRIVATE LTD.

Nippon India Pharma Fund Direct Plan Payout Inc Dist cum Cap Wdrl

Add To Compare

previously known as Nippon India Pharma Dir DP until

170.804 (1.900%)
NAV on July 26, 2024
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 7,404 cr
Turnover Ratio 18.67%
Expense Ratio 0.92%
Exit Load 1.00%if redeemed within
1 Months0.00%if redeemed after 1 Months
Returns
  • 1M: 6.70%
  • 1Y: 42.79%
  • 3M: 11.14%
  • 3Y: 16.90%
  • 6M: 16.21%
  • 5Y: 30.60%
Min Investment 5,000
Buy Now Start SIP
ADDITIONAL INFO
Fund Manager Sailesh Raj Bhan (Since over 19 years) Kinjal Desai (Since about 6 years)
ISIN INF204K01I35
Fund Family Nippon India
P/E Ratio 38.17
P/B Ratio 6.10
Launch Date January 01, 2013
Benchmark BSE Healthcare TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs BSE Healthcare TR INR

Alpha 2.25
Beta 0.89
R-Squared 93.67
Info Ratio 0.42
Tracking Err 3.92
Sortino 1.192
Sharpe 0.711
Std Dev 14.111
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 0.0%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 100.00%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

This fund may declare and pay out a dividend to you on a periodic basis, but only when it has the profits to do so.

View Factsheet
-
Best Sector Healthcare Funds
NAME LATEST
NAV		 RETURNS
1y     		FUND
ASSETS		 Expense
RATIO		 RISK
Quant
Quant Healthcare Fund Direct Growth
16.368 62.21% 302 cr 0.68% -
Icici
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth
37.660 53.21% 4,125 cr 1.07% -
Uti
UTI Healthcare Fund-Growth Option- Direct
287.671 48.34% 986 cr 1.3% -
Tata
Tata India Pharma & Healthcare Fund Direct Growth
32.694 48.00% 949 cr 0.79% -
Sbi
SBI Healthcare Opportunities Fund Direct Growth
422.123 38.62% 2,760 cr 0.94% -


Other plans of Nippon India Pharma


Other Equity funds by Nippon India

Data Partner
Click here to visit AMC website and
read all scheme related documents Nippon India Fund